Introduction
============

Compensatory adult neurogenesis has been demonstrated in many models of brain injury and neurodegeneration, including stroke, trauma, epilepsy, excitotoxic lesioning, Huntington's and Parkinson's disease^\[[@b1]-[@b9]\]^. However, complete neuronal repair is yet to be achieved. In the normal adult mammalian brain, neurogenesis is predominantly observed from the subventricular zone (SVZ) of the lateral ventricles and throughout the olfactory bulb system, as well as the dentate gyrus of the hippocampus. Specifically in the SVZ, slow dividing Type B stem cells generate rapidly proliferating Type C cells (transiently amplifying precursors or TAPs) that can generate both neuroblasts and oligodendrocytes^\[[@b7],\ [@b10]\]^. TAPs have been found to be heterogeneous and express combinations of the pro-neurogenic genes *Mash1, Pax6, Ngn2, Dlx2* and the oligodendrocyte lineage gene *Olig2*^\[[@b2],\ [@b11]-[@b16]\]^. Neural cell loss or injury in the adult brain can alter endogenous neurogenesis and elicit a compensatory repair process. Specifically, alterations in the expression of *Mash1, Pax6, Ngn2, Dlx2* and/or *Olig2* have been observed in the adult SVZ and parenchyma in various models of neural cell loss, consistent with their potential roles in the endogenous repair process^\[[@b2],\ [@b8],\ [@b9],\ [@b16]-[@b19]\]^.

If endogenous repair is to be restorative, attraction of the appropriate cellular phenotype to repopulate and repair damaged areas of the brain is essential. After injury, SVZ neural progenitor cells (NPCs) have been found to be redirected to areas of neural cell loss and either, 1) stay in their original neuronal lineage program^\[[@b20],\ [@b21]\]^; 2) change their lineage program to a different neuronal subtype^\[[@b22],\ [@b23]\]^; or 3) have their lineage altered to a different cell type altogether^\[[@b24]\]^. However, the plasticity of these cell lineages differ between injury and disease models in the appropriate recruitment and differentiation of sub-type specific cells. Why this happens is not well understood. We previously showed that quinolinic acid (QA) -induced striatal cell loss stimulates a transient neurogenic response from SVZ-derived precursor cells, with increased proliferation and redirected migration of cells away from the SVZ and rostral migratory stream to the injury site^\[[@b6]\]^. Retrovirus (RV) GFP lineage tracing found the phenotype of redirected cells appeared to change over time from a neuronal to glial morphology^\[[@b25]\]^. Classically, endogenous repair studies have focused on the proliferation of SVZ progenitors labelled with Bromodeoxyuridine or with RV-GFP, to track the migration of DCX+ precursor cells to areas of neural damage and determine the neural phenotypes generated, while ignoring non-DCX+ migratory cells^\[[@b6],\ [@b22],\ [@b23],\ [@b25],\ [@b26]\]^. To address this, the current study examined the phenotypic profiles of all RV-GFP labelled cells migrating from the SVZ into the QA lesioned striatum over time. Interestingly, GFP+ cells observed in the injured striatum included migratory neuroblasts as well as bipolar *Olig2+* cells, with the predominant response observed from glial cells.

We attempted to override this glial response by ectopic expression of the pro-neurogenic genes, *Pax6* or *Dlx2* in the adult rat SVZ following QA acid lesioning. Pro-neurogenic transcription factor delivery has been examined as a way to enhance a neurogenic response following neural injury^\[[@b2],\ [@b17]-[@b19],\ [@b27],\ [@b28]\]^. Based on the presence of oligodendrocyte precursor cells (OPCs) in response to QA-induced striatal cell loss, we investigated the effect of over-expressing the pro-neurogenic factors *Pax6* and *Dlx2.* Studies have demonstrated the requirement of *Pax6* as a 'master regulator' of neurogenesis in the adult brain. *Pax6* acts to suppress the glial transcription factor *Olig2* in the adult SVZ and to reprogram postnatal glia and reactive astrocytes into neurons^\[[@b12],\ [@b13],\ [@b15],\ [@b29],\ [@b30]\]^. Repression of *Olig2* or overexpression of *Pax6* was able to promote neuroblast generation in a cortical stab wound injury and post striatal ischemia^\[[@b18],\ [@b19]\]^. *Olig2* has also been shown to interfere with *Dlx2* expression and neuroblast fate in the normal SVZ^\[[@b31]\]^. Therefore, in order to determine if the observed gliogenic fate post QA lesioning could be overcome, we delivered retrovirus expressing either *Pax6* or *Dlx2* with *GFP* directly to SVZ precursor cells at time points where significant progenitor cell recruitment had been observed. Interestingly, only RV-Dlx2 over-expression enhanced both neuroblast recruitment and the percentage of recruited cells that retained a neuronal fate when compared to RV-GFP control animals. Surprisingly, RV-Pax6 expression resulted in increased OPC numbers with no change in neurogenesis when compared to controls. These findings suggest that signals released from damaged tissue can selectively override pro-neurogenic gene expression. Therefore, a better understanding of interactions between neural precursor cells and inflammatory signals is required in order to successfully regenerate cells endogenously for injury or disease.

Materials and Methods
=====================

All experimental protocol were approved by the University of Auckland. Animal work was carried out with strict accordance to guidelines set by the University of Auckland Animal Ethics Committee in accordance with the New Zealand Animal Welfare Act 1999 and conformed to international guidelines for the ethical use of animals. Retroviral generation was approved by the University of Auckland and conformed to the Environmental Protection Authority of New Zealand.

Retroviral generation
---------------------

pMXIG-GFP, pMXIG-Dlx2-GFP and pMXIG-Pax6-GFP plasmids were kindly donated by Professor Magdalena Gotz (Department of Physiological Genomics, Ludwig-Maximilians University, Munich, Germany)^\[[@b12],\ [@b13],\ [@b29]\]^. RV-GFP, RV-Pax6-GFP and RV-Dlx2-GFP retroviral particles were generated and concentrated as per previously described methods^\[[@b25]\]^.

Surgical procedures
-------------------

Adult male Wistar rats weighing 250-300g (three months of age; University of Auckland Vernon Jansen Unit) were used in this study. The animals were housed in a temperature and humidity controlled room that was kept on a 12 hour light and dark cycle. Food and water were available *ad libitum.* Animal welfare was monitored daily. Every effort was made to minimize the number of animals used and their suffering. For excitotoxic lesions, 400nl of fresh 50nM quinolinic acid (QA) pH 7.4 was injected unilaterally into the striatum at the following coordinates: AP +0.7mm, ML -2.5mm relative to bregma, and DV -5.0mm relative to dura. Control animals did not receive a sham injection as our previous findings have demonstrated that sham surgery resulted in no significant difference to SVZ proliferation or neural precursor cell migration^\[[@b25]\]^. For RV injections, 2μl of concentrated retrovirus (RV-GFP, RV-Pax6-GFP or RV-Dlx2-GFP, titre 1x10^8^ colony forming units (cfu)/ml) containing 80μg/ml polybrene) was injected unilaterally at the following co-ordinates: AP +0.2mm, ML -1.7mm, relative to bregma and DV -3.4mm relative to dura. RV-GFP was injected two days prior to lesioning, on the day of lesioning and two, three, five and seven days post lesion (n=3-5 per time point)^\[[@b25]\]^. RV-Pax6-GFP and RV- Dlx2-GFP were injected on the day of lesioning or two days post lesion (n=5-6 per virus per time point). RV control animals received an injection of either RV-Pax6- GFP or RV-Dlx2-GFP into the SVZ but received no QA or sham lesion (n =3-4). All animals, including controls, were transcardially perfused five days post RV injection to allow the same amount of time for cells to respond to lesion-induced signals and migrate. Perfusion was with ice cold 0.9% saline, followed by 400ml 4% paraformaldehyde in 0.1M phosphate buffer pH 7.4. Brains were removed and post fixed overnight at 4^o^C in 4% paraformaldehyde, then cryoprotected in 30% sucrose in 0.1M phosphate buffer pH 7.2. Sectioning was carried out in sagittal orientation with 40μm between each section.

Immunohistochemistry
--------------------

Sections were washed 3 x 5 minutes in 1X PBS and 3 x 5 minutes in 1X PBS + 0.2% Triton X-100. Primary antibodies were incubated at room temperature overnight in immunobuffer containing 3% donkey or goat serum in 1X PBS + 0.2% Triton. Primary antibodies used were: GFP (chicken polyclonal, 1:500, Abcam), GFP (rabbit polyclonal, 1:1000, Abcam), Doublecortin C-terminus (goat polyclonal, 1:300, Santa Cruz), NG2 (rabbit polyclonal, 1:300, Chemicon), GFAP (mouse monoclonal, 1:2000, Sigma), Pax6 (rabbit polyclonal, 1:1000, Covance), Dlx2 (rabbit polyclonal, 1:500, Abcam), Olig2 (rabbit polyclonal, 1:500, Chemicon), Brg1 (mouse monoclonal, Santa Cruz 1:100). Sections were then incubated at room temperature for 4 hours in secondary antibodies in immunobuffer. Secondary conjugated antibodies used were goat anti- chicken Alexa Fluor 488, donkey anti-rabbit Alexa Fluor 488, donkey anti-goat Alexa Fluor 594, donkey anti-rabbit Alexa Fluor 594, donkey anti-mouse Alexa Fluor 647 and donkey anti-rabbit Alexa Fluor 647 (all 1:500, Invitrogen).

Quantitative PCR
----------------

SVZ tissue was isolated from the brains of QA lesioned animals at 1, 2, 3 and 7 days post lesion (n=3-4). RNA was extracted using the Qiagen Lipid Tissue RNeasy Mini Kit and cDNA synthesized using the SA Bioscience RT^2^ First Strand Kit with 400ng purified RNA. Quantitative SYBRgreen PCR was performed on an ABI 7900HT machine and the RT^2^ Profiler PCR Array System using a customised SA Biosciences Rat Neurogenesis and Neural Stem Cell PCR Array (PARN 404). SA Bioscience software calculated fold regulatory changes using the ΔΔ Ct method^\[[@b32]\]^ between gene expression in the QA lesioned SVZ compared to control SVZ, normalised to the arthritic mean Ct of the three most stable housekeeping genes of five run *(Rplp1* -- Ribosomal protein, large P1, *Rpl13a* -- Ribosomal protein L13A and *Ldha* -- Lactate dehydrogenase A. Also run were *Hprt1* -- Hypoxanthine phosphoribosyltransferase 1 and *Actb* -- Beta actin).

Microscopy
----------

GFP-labelled cell counts and morphological analysis was performed under a 40x oil lens on a Zeiss Axioplan fluorescent microscope. DCX, NG2, GFAP, Dlx2, Pax6 and Olig2 immunostaining was imaged at 40x on a Zeiss inverted LSM fluorescent confocal microscope in z series with 3.4μm between each slice, with a tile scan to cover the entire striatum.

Statistical Analysis
--------------------

The number of GFP-labelled cells observed in the lesioned striatum was totalled from 12 sections per animal, per time point, per virus. Cell numbers were totalled per animal and an average GFP-labelled cells per section calculated. For RV-GFP morphology analysis over time a two way ANOVA was performed. For comparisons of RV-GFP-labelled cells per timepoint a one way ANOVA followed by an all-pair wise Dunnet's multiple comparison post hoc test was performed to compare between groups. GFP-labelled cell co-expression with DCX, Olig2, NG2 or GFAP was quantified from three sections per animal, per time point, per virus. Group values were averaged and reported as the mean +/- standard error of the mean. For comparisons between RV-GFP, RV-Dlx2-GFP and RV-Pax6-GFP labelled cells, a one way ANOVA followed by an all-pair wise Dunnet's multiple comparison post hoc test to compare between groups was used. Control GFP (no QA lesion), day 0 and day 2 RV injection groups were analyzed separately. For qPCR, the normalized fold changes for each group of animals was compared to the normalized fold change of the control group using the student's t test, provided by the SA Biosciences software. Results were considered significant if p\<0.05.

Results
=======

Excitotoxin-induced striatal cell loss stimulates recruitment of neuroblasts and oligodendrocyte precursor cells from the subventricular zone into the lesioned striatum
------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Replication incompetent, pseudotyped GFP retrovirus was injected into the SVZ of QA lesioned animals or non-lesioned controls at a range of time points prior to or following QA injection ([Figure 1a-b](#fig1){ref-type="fig"}). Retrovirus has previously been shown to only infect fast dividing cells, including *in vivo* in the adult rodent SVZ^\[[@b33]-[@b36]\]^, allowing birth dating and tracking of migration of newborn SVZ-derived precursor cells. Sham-injected (0.9% saline) controls were carried out previously^\[[@b25]\]^ and no striatal migration from SVZ-labelled progenitors was found, with GFP labelled cells remaining within the RMS and migrating normally to the olfactory bulb. Therefore, no chemotaxic property due to injury or inflammation was caused by the surgery alone. To minimize the number of animals used in this study sham controls were not repeated. GFP+ cells recruited into the QA lesioned striatum were quantified 5 days post RV-GFP injection to allow time for migration. In unlesioned control animals GFP cells were found in the SVZ, throughout the RMS ([Figure 1c](#fig1){ref-type="fig"}) and olfactory bulb but not in the striatum. In lesioned animals, in agreement with our previous observations^\[[@b25]\]^, GFP-labelled cell recruitment was observed by cells born either two days prior to QA lesioning through to 7 days following QA lesioning, with both bipolar and multipolar phenotypes observed ([Figure 1d-i](#fig1){ref-type="fig"}). Significantly more GFP-labelled cells were recruited into the QA lesioned striatum from SVZ progenitors that were born on the day of QA lesioning or two days post QA lesion when compared to controls ([Figure 1j](#fig1){ref-type="fig"}; one way ANOVA=0.0032; Dunnett's post hoc test between time points and control p\<0.05). At 3, 5 and 7 dpl (days post lesion) small numbers of GFP+ cells labelled were found in the striatum, SVZ and RMS, but the number of GFP cells in the striatum was not significantly different compared to non-lesioned controls.
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GFP-labelled cells exhibited either bipolar or multipolar phenotypes^\[[@b37]\]^ and the ratio of these cell types was altered in a temporal manner^\[[@b25]\]^ ([Figure 1d-i, k](#fig1){ref-type="fig"}), with a significant change in morphology observed over time (two way ANOVA F6,51=2.941 p=0.019). GFP+ cells labelled on the day of QA lesioning exhibited similar numbers of bipolar and multipolar morphologies, with significantly more bipolar cells in the striatum compared to controls ([Figure 1k](#fig1){ref-type="fig"}; one way ANOVA p=0.0016, Dunnett's post hoc test p\<0.01). In contrast, there were significantly more multipolar cells labelled 2 days following QA lesioning when compared to controls ([Figure 1k](#fig1){ref-type="fig"}; one way ANOVA p=0.013; Dunnett's post hoc test p\<0.05). These results suggest that a switch in cell fate may be occurring within the QA lesioned striatum over time.

Bipolar cells recruited from the SVZ are routinely described as neuroblasts. Interestingly, while we observed a significant increase in the number of DCX/GFP labelled cells migrating into the striatum from cells labelled on the day of QA lesioning compared to unlesioned controls ([Figure 2a, c and g](#fig2){ref-type="fig"}; one way ANOVA p\<0.0001; Dunnett's post hoc test p\<0.001), characterization also indicated the recruitment of bipolar OLIG2/GFP labelled OPCs from the SVZ ([Figure 2b and d](#fig2){ref-type="fig"}). GFP-labelled multipolar cells were found to almost exclusively co-label with the oligodendrocyte markers, OLIG2 and/or NG2 ([Figure 2b, e and f](#fig2){ref-type="fig"}). However, both bipolar and multipolar GFP-labelled cell populations contained lineage negative cells that could not be characterized with any of the markers examined including DCX, NG2, GFAP, OLIG2, MASH1, DLX2, or PAX6 ([Figure 2h-i](#fig2){ref-type="fig"}). Striatal lineage negative cells were generated from GFP-positive cells at all time points following QA lesioning and were especially prominent in the bipolar cell population. While positive staining was observed with MASH1/GFP, DLX2/GFP and OLIG2/GFP in cells within the SVZ (Supplementary [Figure 1](#SD1){ref-type="supplementary-material"}) and for DLX2/GFP and DCX/GFP throughout the RMS (Supplementary [Figure 2](#SD2){ref-type="supplementary-material"}), RV-GFP-labelled cells in the striatum were never found to express either MASH1 or PAX6 indicating either specific recruitment of subtypes of neural precursor cells in the different regions of the brain or down-regulation of specific pro-neurogenic genes in recruited cells. Further, GFAP expression was never observed in any GFP-labelled cells in either the striatum or the SVZ indicating that RV-GFP was not transducing slow dividing Type B stem cells in the SVZ or proliferating GFAP+ glia and that there was no recruitment of GFAP+ glia or stem cells from the SVZ into the lesioned striatum (Supplementary [Figure 7](#SD7){ref-type="supplementary-material"}). DCX has previously been observed to co-label with NG2 in the cortex, however confocal imaging confirmed that DCX+ neuroblasts in the SVZ and migrating DCX+ cells in the lesioned striatum did not label with NG2 (Supplementary [Figure 3](#SD3){ref-type="supplementary-material"}), confirming their neuronal fate.
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RV-Pax6 over-expression alters the number of striatal GFP cells with multipolar-glial cell phenotypes
-----------------------------------------------------------------------------------------------------

Previous studies have shown *Pax6* and *Dlx2* to have a potent neurogenic effect in the adult brain, and *Pax6* coupled with *Olig2* repression able to promote neurogenesis in injury models^\[[@b13],\ [@b18],\ [@b19],\ [@b29]-[@b31]\]^. Based on these previous studies and our lineage tracing results, we investigated whether RV delivery of the pro-neurogenic genes *Pax6* or *Dlx2* directly to precursor cells in the SVZ could overcome the predominantly gliogenic fate of recruited cells migrating into the QA lesioned striatum. We also examined whether *Pax6* or *Dlx2* over-expression would reprogram lineage negative cells towards a neuronal fate. RV-Dlx2-GFP or RV-Pax6-GFP was injected into the SVZ of non-lesioned control animals and reliable co-expression of transgenes with GFP was observed (Supplementary [Figure 4a-c](#fig4){ref-type="fig"} and 5a-c). GFP+ cells remained in the SVZ and RMS of unlesioned animals and did not migrate into the striatum (Supplementary [Figure 6](#SD6){ref-type="supplementary-material"}^\[[@b25]\]^). RV-Dlx2-GFP or RV-Pax6-GFP was injected into the SVZ either on the day of QA lesioning or 2 days following QA lesioning ([Figure 3a](#fig3){ref-type="fig"}), the time points when significant recruitment of GFP-labelled cells was previously observed ([Figure 1j](#fig1){ref-type="fig"}). To determine the effect of *Pax6* or *Dlx2* on the recruitment of GFP-labelled cells from the SVZ, total GFP+ cell number was quantified in the striatum for both RV-Pax6 and RV-Dlx2 treated animals. Percentages of GFP-labelled cells in the striatum expressing DCX, OLIG2, NG2 and GFAP were also calculated to examine the effect of *Pax6* or *Dlx2* over-expression on precursor cell lineage following recruitment to the striatum.

Surprisingly, over-expression of *Dlx2* and *Pax6* gave very different results in relation to the number of GFP-labelled cells recruited to the QA lesioned striatum, even though the viruses had identical titres and therefore infected a similar number of cells upon injection into SVZ. Percentages of cells exhibiting a neuronal fate once recruited into the damaged area were also different between groups. We observed that injection of RV-Pax6 in the SVZ on the day of QA lesioning (day 0) led to a significant reduction in the total number of GFP labelled cells recruited to the lesioned striatum ([Figure 3b](#fig3){ref-type="fig"}, red bars), including a decrease in the number of bipolar cells ([Figure 3c](#fig3){ref-type="fig"}) and DCX+ neuroblasts ([Figure 3d](#fig3){ref-type="fig"}) when compared to RV-GFP controls (green bars). However, when RV-Pax6 was injected two days post lesion, an increase in the recruitment of GFP-labelled cells to the striatum was observed ([Figure 3b](#fig3){ref-type="fig"}).

Interestingly, the morphology of these cells was predominantly not bipolar ([Figure 3c](#fig3){ref-type="fig"}) and the number of DCX+ cells was unchanged when compared to RV-GFP control animals ([Figure 3d](#fig3){ref-type="fig"}). Instead, we observed a significant increase in a multipolar phenotype of GFP-labelled cells in the lesioned striatum in animals injected with RV-Pax6 two days post lesion ([Figure 3f](#fig3){ref-type="fig"}) and an increase in NG2 cell number when compared to RV-GFP controls ([Figure 3g](#fig3){ref-type="fig"}). However, when the percentage of striatal GFP cells co-expressing subtype specific markers was examined following RV-Pax6 over-expression, we observed that Pax6-GFP+ cells redirected into the QA lesioned striatum retained the same fate profile as RV- GFP controls with no significant alteration observed in the percentage of bipolar cells that expressed either OLIG2 or DCX ([Figure 3j-k](#fig3){ref-type="fig"}) or percentage of multipolar cells expressing NG2 when compared to RV-GFP control animals ([Figure 3l](#fig3){ref-type="fig"}). These results indicate that Pax6 over-expression was unable to promote SVZ-derived precursor cells to a neuronal fate following recruitment into the QA lesioned striatum.

Dlx2 enhances neuroblast recruitment and retention of a neuronal fate in the QA-lesioned striatum
-------------------------------------------------------------------------------------------------

In contrast to *Pax6,* injection of RV-Dlx2 in the SVZ had no effect on the total number of GFP-labelled cells recruited into the striatum at either time point examined ([Figure 3b](#fig3){ref-type="fig"}, blue bars). Further, RV-Dlx2 had no effect on the morphology of GFP+ cells or on DCX+, OLIG2+ or NG2+ cell numbers when injected on the day of QA lesioning (Day 0, [Figure 3c-g](#fig3){ref-type="fig"}). However, we observed that injection of RV-Dlx2 2 days following lesioning significantly increased both the number of bipolar GFP-labelled cells ([Figure 3c](#fig3){ref-type="fig"}) and the number of DCX/GFP neuroblasts compared to controls ([Figure 3d](#fig3){ref-type="fig"}) while not changing the number of multipolar cells or affecting OLIG2 or NG2 cell number ([Figure 3e-g](#fig3){ref-type="fig"}). Notably, when labelled at 2 days post lesion, the percentage of bipolar cells was significantly increased in the striatum ([Figure 3h](#fig3){ref-type="fig"}) and the percentage of DCX/GFP neuroblasts was also significantly increased to \~ 25% of the bipolar GFP+ population when compared to controls ([Figure 3j, m-o](#fig3){ref-type="fig"}). This occurred in conjunction with a significant reduction in multipolar cell fate ([Figure 3i](#fig3){ref-type="fig"}), while percentages of OLIG2/GFP and NG2/GFP expressing cells remained unchanged ([Figure 3k-l](#fig3){ref-type="fig"}). This may indicate that ectopic *Dlx2* expression can induce lineage negative GFP cells to a neuronal fate.
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Interestingly, while both ectopic DLX2 and PAX6 could be detected in 83-92% of all RV-GFP labelled cells in SVZ of non-lesioned control animals (Supplementary [Figure 4 a-c](#SD4){ref-type="supplementary-material"} and [5 a-c](#SD5){ref-type="supplementary-material"}), down-regulation of transgenes was observed in the majority of GFP-labelled cells recruited into the striatum from animals injected at 2 days post lesion ([Figure 4 a-f](#fig4){ref-type="fig"}). Only 2-3% of striatal GFP+ cells remained expressing PAX6 and DLX2. Similarly while *Brg1,* an essential gene for the pro-neurogenic function of bipolar SVZ PAX6 progenitor cells^\[[@b38]\]^, was observed in the SVZ of bipolar RV-PAX6-GFP cells ([Figure 4 g-j](#fig4){ref-type="fig"}) and some GFP+ multipolar cells near to the RMS, it was absent in multipolar RV-PAX6-GFP+ cells in the striatum, of which some also stained for NG2 ([Figure 4k, l-s](#fig4){ref-type="fig"}). This further indicates the loss of neuronal function in RV-PAX6 recruited cells. These findings indicate that *Dlx2,* while downregulated in many GFP cells of the striatum, does retain a significant effect on both the recruitment and regulation of DCX+ neuroblasts within the damaged striatum at acute time points post QA lesion.
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PAX6 expression from RV-Pax6-GFP (a-c) and DLX2 expression from RV-Dlx2-GFP (d-f) is down-regulated in the lesioned striatum from cells labelled at 2dpl. Arrowheads show few remaining positive co-expressing cells. (g-j) Bipolar RV-Pax6-GFP cells (green) in the SVZ co-express PAX6 (red) and BRG1 (blue). Arrowheads indicate two triple labelled cells. (k-s) In RV-Pax6-GFP animals, a few BRG+ / multipolar GFP+ cells are observed close to the SVZ and RMS (l-o, upper boxed area), however all GFP+ multipolar cells further into the lesioned area and all NG2 / GFP+ cells are BRG negative (p-s, lower boxed area). Scales a-f = 50 μm, boxed area a-f 12.5 μm, g-j and l-s = 20 μm and k = 200 μm

The expression of signalling molecules in the SVZ following QA-induced striatal injury
--------------------------------------------------------------------------------------

Using quantitative PCR, we examined mRNA expression of a number of signalling molecules in the SVZ at 1, 2, 3 and 7 days post lesion in order to identify QA lesion-induced changes that may be implicated in the phenotypic switch of neural precursor cells in the lesioned environment. Changes in mRNA expression were observed in many of the main signalling families, including the BMP and Notch pathways and in molecules that are known to regulate the proliferation and migration of neural precursor cells ([Table 1](#tbl1){ref-type="table"}).

*Bmp4, Hey1, Heyl, Tnr* and *pleiotropin* mRNA expression was reduced in the first 1-2 days post QA lesion, then *Bmp4, Tnr* and *pleiotropin* significantly increased at 3 days post lesion, and *Hes1* at 7dpl when compared to unlesioned controls. *Stat3* was increased throughout the time course, while *Noggin* was significantly increased at day 3. Further, a range of genes including *Robo1, Smad4* and *BMP2* were significantly reduced from day 1 up to days 3 to 7 post QA lesion. In addition, we observed a significant increase in the expression of *Fgf2* and *Bdnf* mRNA from 1 to 3 days post QA lesion while expression of *Fgf13* and *Vegf* mRNA was reduced when compared to unlesioned controls.

                 **1 dpl**    **2 dpl**    **3 dpl**    **7 dpl**                                           
  -------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
  **Gene**       **Fold Δ**   **Sig.**     **Fold Δ**   **Sig.**     **Fold Δ**   **Sig.**     **Fold Δ**   **Sig.**
  ***Bdnf***     **11.4**     \*           **18.4**     \*           **4.0**      \*           11.2         ns
  ***Fgf2***     **4.1**      **\*\*\***   **1.7**      \*           **1.8**      \*\*         1.6          ns
  ***Fgf13***    **-2.8**     \*\*         **-1.7**     \*           **-3.2**     \*\*         1.3          ns
  ***Vegf***     **-2.6**     **\*\*\***   **-1.9**     **\*\*\***   **-2.0**     **\*\*\***   **-1.7**     **\*\*\***
  ***Bai1***     **-3.3**     \*\*         **-1.4**     \*\*         **-1.5**     \*           1.1          ns
  ***Artn***     **-1.8**     \*\*         1.0          ns           **-2.2**     \*\*         1.0          ns
  ***Fez1***     **-2.9**     **\*\*\***   **-1.6**     **\*\*\***   **-1.4**     \*\*         -1.2         ns
  ***Ptn***      **-1.6**     **\*\*\***   1.1          ns           **1.7**      **\*\*\***   1.0          ns
  ***Mdk***      **-1.3**     \*\*         **-1.5**     \*\*         1.1          ns           1.4          ns
  ***Nrg1***     **-2.1**     **\*\*\***   1.4          ns           **-2.9**     \*\*         1.1          ns
  ***Bmp2***     **-3.0**     \*\*         **-3.6**     \*\*         **-2.2**     \*           **-2.1**     \*
  ***Bmp4***     **-2.4**     \*\*         -1.4         ns           **2.4**      \*\*         **1.7**      \*
  ***Smad4***    **-1.3**     \*\*         **-1.4**     **\*\*\***   -1.2         ns           1.0          ns
  ***Noggin***   -1.6         ns           1.1          ns           **1.8**      \*\*         1.3          ns
  ***Stat3***    **4.2**      **\*\*\***   **2.2**      \*\*         **2.6**      **\*\*\***   **2.0**      \*\*
  ***Nrp2***     **2.3**      **\*\*\***   **1.7**      \*\*         **2.1**      \*\*         3.7          ns
  ***Nrp1***     1.1          ns           1.6          ns           **2.0**      \*\*         **2.1**      \*
  ***Robo1***    **-2.7**     **\*\*\***   **-1.4**     \*\*         **-1.6**     \*           -1.1         ns
  ***Ntn1***     **-2.2**     **\*\*\***   **-1.5**     \*\*         -1.2         ns           -1.3         ns
  ***Hes1***     1.1          ns           1.1          ns           1.5          ns           **1.8**      \*\*
  ***Heyl***     **-3.1**     **\*\*\***   **-1.7**     \*\*         1.1          ns           -1.2         ns
  ***Hey1***     **-3.0**     **\*\*\***   **-1.8**     \*\*         -1.1         ns           -1.3         ns
  ***Notch2***   1.0          ns           -1.1         ns           1.5          ns           1.3          ns
  ***Tnr***      **-2.2**     **\*\*\***   -2.1         ns           **2.0**      **\*\*\***   1.2          ns

***mRNA expression levels of signalling molecules in the SVZ following QA striatal lesioning.*** *Fold changes shown in blue represent significant (sig.) down-regulation greater than 1.5 fold compared to unlesioned control; fold changes shown in red represent significant up-regulation greater than 1.5 fold compared to unlesioned control. Sign. = Significance; dpl = days post lesion; \* P\<0.05, \*\* P\<0.01, \*\*\* P \<0.001, ns=not significant.*

Discussion
==========

While compensatory adult neurogenesis has been demonstrated in many models of brain injury, the correct cell types are not always generated for successful endogenous repair. We previously described transient SVZ precursor cell recruitment into the striatum following an excitotoxic injury, which exhibited a predominantly glial response^\[[@b6],\ [@b25]\]^. We have now confirmed that recruited cells of a bipolar morphology represent both neuroblasts and oligodendrocyte progenitor cells and that a proportion of multipolar cells are oligodendrocyte progenitors, but not astrocytes. Results observed in a Nestin-CreER^T2^ :R26R-YFP mouse stroke model reported similar percentages of recruited Dcx and NG2 progenitors as reported in our RV-GFP study, at 6 weeks post injury, but also identified a large percentage of GFAP+ astrocytes recruited into the striatum^\[[@b39]\]^. Astrocyte recruitment is not observed in our QA lesion model at the time points we examined, indicating endogenous repair mechanisms do vary between disease models and perhaps between species^\[[@b39]\]^.

Pro-neurogenic transcription factor delivery has been trialled as a mechanism to enhance the regenerative response to neural damage, with studies demonstrating moderate success when injecting pro-neurogenic transcription factors directly into damaged brain parenchyma^\[[@b12],\ [@b17]-[@b19],\ [@b27],\ [@b28]\]^. The current study therefore aimed to convert the observed gliogenic response to a neurogenic one by individually over-expressing the pro-neurogenic genes *Pax6* or *Dlx2* in SVZ-derived neural precursors. Interestingly we found that only ectopic *Dlx2* expression was able to overcome signals released from damaged tissue and enhance both neuroblast recruitment and the percentage of recruited cells that retained a neuronal fate in the QA lesioned striatum. We propose this may reflect the importance the microenvironment plays in regulating neural cell fate following injury or disease.

While it is believed that *Dlx2* and *Pax6* may have similar roles in promoting adult SVZ neurogenesis^\[[@b12],\ [@b40]\]^, very different results were observed in the current study following *Dlx2* over-expression when compared to *Pax6.* This may be explained by different complements of chemokine receptors on PAX6+ and DLX2+ precursor cells, as inflammatory-induced chemoattractants play an essential role in neuroblast and OPC recruitment^\[[@b3],\ [@b41]-[@b44]\]^ and have been shown to be expressed in the QA lesioned striatum^\[[@b41],\ [@b42]\]^. While DLX2+ precursor cells have been observed to migrate towards chemoattractants during forebrain development^\[[@b45]\]^, expression of chemokine receptors specifically on adult SVZ-derived PAX6+ or DLX2+ precursor cells has never has been examined. We thus propose the pan-cell type decrease in Pax6-GFP cells observed in the striatum of animals labelled at the time of QA lesioning may indicate that RV-Pax6 over-expression has generated PAX6+ precursor cells (possibly TAPs) which either do not express the complement of chemokine receptors required to respond to migratory cues released from the QA lesioned striatum at the time of lesioning or chemokines that attract PAX6+ precursor cells may not be secreted from the QA lesioned striatum at this immediate time point. Lack of appropriate chemokine signalling is likely because PAX6+ cells labelled two days post lesioning were recruited in large numbers to lesioned striatum. It is also possible that the RV-Pax6 cells are recruited into the striatum to a similar extent as the GFP and RV-Dlx2 cells, but do not survive at the early time point, while increasing proliferation at the latter time point. Further analysis is required however to identify the chemokine/signalling molecule(s) responsible for this *Pax6*-dependant effect.

In contrast, *Dlx2* over-expression at both time points examined did not lead to a change in the number of recruited GFP+ cells to the striatum, suggesting these cells may be responding to a different chemokine or complement of chemokines. Over-expression of *Dlx2* has been shown to promote reprogramming of adult cortical astroglia into functional GABAergic neurons *in vitro,* under both normal conditions and in cortical astrocytes responding to injury^\[[@b46],\ [@b47]\]^. *Dlx2* is also believed to repress oligodendrogenesis by suppressing *Olig2* in the adult SVZ through a BMP mediated mechanism^\[[@b31]\]^. Consistent with this, RV-DLX2 expression did increase total bipolar GFP+ cell recruitment and DCX+ cell number, in conjunction with a reduction in multipolar GFP+ cell number when compared to RV-GFP control animals. However, as OLIG2+ and NG2+ cell numbers remained unchanged this suggests that instead of suppressing *Olig2* expression, *Dlx2* may be altering the fate of the lineage negative GFP+ cells identified in controls. While DCX has been observed to co-label with NG2 in the cortex^\[[@b48]\]^, confocal imaging confirmed that DCX+ neuroblasts in the SVZ and migrating into the lesioned striatum do not express NG2, establishing their neuronal fate in the striatum. Unfortunately, staining for mature neuronal markers was not able to be performed due to the immature fate of the cells. Therefore, in contrast to *Pax6, Dlx2* over-expression in SVZ precursor cells has a significant neurogenic effect within the QA lesioned striatum.

In contrast to previous work^\[[@b18],\ [@b19]\]^, we observed that over-expression of *Pax6* in SVZ-derived precursor cells was unable to promote an increase in DCX+ cell recruitment in the QA lesioned striatum. Instead, ectopic PAX6 expression appeared to promote an oligo-glial cell fate. Ninkovic and colleagues^\[[@b38]\]^ have reported that adult SVZ neurogenesis regulated by *Pax6* is co-dependant on a Brg-containing BAF chromatin remodelling complex. Loss of either *Pax6* or *Brg1* alters the fate of adult SVZ-derived precursor cells. Specifically, in the parenchyma surrounding the SVZ and RMS, loss of *Pax6* or *Brg1* altered neuroblast lineage to OLIG2+ and/or NG2+ OPCs, starting in the RMS and this effect was specific to PAX6 progenitors. While we saw positive staining of RV-PAX6-GFP cells with PAX6 and BRG1 in the SVZ, we also observed an absence of PAX6 and BRG1 in RV-PAX6-GFP cells in the striatum that acquired a multipolar fate and some of which were positive for NG2. This suggests signals released after QA lesioning may be promoting the alteration of SVZ-derived *Pax6*-expressing cells to an oligodendroglial fate, resulting in the reduction in DCX+ neuroblasts observed. We also observed some BRG1+ immunostaining for RV-DLX2-GFP cells in both bipolar and multipolar cells of the striatum (data not shown), indicating a different regulatory role for *Brg1* to the one it plays for *Pax6.* This is unsurprising as *Brg1* control of neurogenesis was found to be specific for *Pax6^\[[@b38]\]^.* Jablonska and colleagues (2010) also found alterations in BMP signals in the SVZ which led PAX6+ neuronal precursor cells to switch their molecular, cellular and migratory paths towards an oligodendrocyte lineage following white matter injury^\[[@b24]\]^. In the current study we also observed alterations in SVZ BMP signalling following QA lesion that could have impacted the increase in glial cell fate found with RV-Pax6. In addition to dynamic changes in *Bmp2* and *Bmp4* expression, we found significant up-regulation of *Stat3, Fgf2, Bdnf, Hes1,* and *Noggin.* These changes were coupled with significant decreases in many other molecules and growth factors indicating the complex environmental regulation within the SVZ precursor pool after injury.

It is interesting to observe such dynamic changes in signalling molecules in the SVZ after a striatal lesion, but it is difficult to fully understand how or in fact which of these molecules are acting specifically on the Dlx2 and Pax6 TAPS or neuroblasts of the SVZ, as to date very few studies have been performed to examine the range of receptors on these cells. Further, when tissue is collected for gene expression analysis the entire SVZ is pooled, resulting in a heterogeneous mix of all cell types. This means only the 'big picture' and not effects on specific cell types can be observed. Further studies are needed to tease out the specific effects of each signalling factor on the individual cells of the SVZ.

Interestingly, two recent papers have identified parenchymal astrocytes in the mouse striatum that can respond to QA lesion or stroke induced signals, up-regulate *Mash1* and generate DCX+ neuroblasts contributing to striatal regeneration^\[[@b8],\ [@b9]\]^. A role for decreased *Notch* signalling within these cells in the striatum was implicated for this endogenous repair mechanism. We also observed down-regulation in some components of the Notch signalling pathway in the SVZ immediately following lesioning, further supporting that lesion-induced cues can alter Notch regulation of SVZ neurogenesis. It is exciting to note that the rodent brain appears to retain the capacity for both acute recruitment of cells from the SVZ immediately following injury (within the first 2 days following QA lesion) and a longer term ability to regenerate neuroblasts from striatal astrocytes activating a neurogenic programme (from 2 weeks post injury)^\[[@b8],\ [@b9],\ [@b25],\ [@b39]\]^. Our study only examined acute time points following striatal lesioning which may be why we did not observe parenchymal astrocyte neurogenesis. Long term survival and differentiation studies on RV-Pax6 and RV-Dlx2 cells will offer more information on fate-switching and the endogenous repair potential from both recruited SVZ cells and neurogenic striatal astrocytes.

Conclusion
==========

The current study demonstrates that RV-Dlx2 over-expression in SVZ-derived progenitors can stimulate acute neuroblast recruitment and retention of a neuronal fate in an excitotoxic lesion model at a previously non-neurogenic time point. In contrast, over-expression of *Pax6* in SVZ-derived progenitor cells was not successful at inhibiting an oligodendrocyte fate and resulted in increased multipolar cell numbers with no change in neuronal recruitment. This indicates a complex interaction between signals released from the lesioned environment and gene expression in recruited cells. To promote successful endogenous repair after injury, we first need to better understand which lesion-induced signals are recruiting the subsets of SVZ progenitors into the striatum, and also how they are altering cell fate determination during this endogenous repair process.
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***Transcription factor expression in GFP-labelled cells in the anterior SVZ of RV-GFP control animals.*** *(a) Image demonstrating the presence of OLIG2 (blue) expression in GFP-labelled (green) bipolar cells in the anterior SVZ (arrowheads) and in multipolar cells in the white matter and striatum (arrows). MASH1 was not observed in GFP cells in this image. (b) Image demonstrating the presence of DLX2 (blue) and MASH1 (red) expression in GFP-labelled bipolar neural precursor cells in the anterior SVZ (arrowheads). Scale bar a-b =50 μm*
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**Gene expression in GFP-labelled cells in the RMS of RV-GFP control animals.** (a-c) Images demonstrating GFP-labelled cells within the central RMS are bipolar neuroblasts expressing DCX, that do not express MASH1 or OLIG2, but of which some are positive for DLX2. (a) GFP (green) / DCX (red). (b) MASH (red) / OLIG (blue) / GFP (green). (c) DLX (blue) / GFP (green). Arrowheads demonstrating the presence of GFP cells co-labelled with DLX2. Scale bar a-c =50 μm.

![](jsrm-12-supp-g003.jpg)

**DCX+ cells in the SVZ and Striatum do not label with NG2** Confocal z projection of (a-c) DCX (red) and NG2 (green). (d-f) represents boxed area in c at higher magnification. All DCX+ cells are negative for NG2 expression. Scale bar a-c = 200 μm and d-f = 50μm
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**Co-localisation of Pax6 transgene with RV-Pax6-GFP in the SVZ of control and QA lesioned animals.** Confocal images of animals showing RV-Pax6-GFP cells (green) overexpressing PAX6 (red) in addition to endogenous NPCs expressing PAX6 in the SVZ of (a-c) unlesioned control animals (d-f) QA lesioned animals at 2 days post RV injection (dpi), (g-i) QA lesioned animals at 5dpi. Arrows indicate some of the co-labelled cells. Scale bar = 50 μm.
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**Co-localisation of Dlx2 transgene with RV-Dlx2-GFP in the SVZ of control and QA lesioned animals.** Confocal images of animals showing RV-Dlx2-GFP cells (green) overexpressing DLX2 (red) in addition to endogenous NPCs expressing DLX2 in the SVZ of (a-c) unlesioned control animals (d-f) QA lesioned animals at 2 days post RV injection (dpi), (g-i) QA lesioned animals at 5dpi. Arrows indicate co-labelled cells. Scale bar = 50 μm.
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**Images of GFP-labelled cells in the RMS of non-lesioned RV overexpression animals.** Images of GFP cells labelled in the RMS of control (no-lesion) animals after RV pro-neurogenic gene overexpression. Cells remain in the RMS and migrate to the olfactory bulb in (a) RV-Dlx2-GFP (scale = 100 μm) and (b) RV-Pax6-GFP (scale = 50μm) with no redirection into the striatum.
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**GFP-labelled cells in the SVZ, RMS and striatum do not co-label with GFAP.** (a-c) GFP labelled cells (green) in the SVZ/RMS of control animals are GFAP negative (red). (d-f) GFP labelled cells (green) recruited into the striatum of lesioned animals at are also GFAP negative (red). Scale bars = 25μm.
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